anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Source Note

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,355
Current window 47,281-47,310
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all
18 30 60

Component

47,281-47,310 of 110,355

filter-aware
159
The slide uses a specific Facebook post as a case study to contradict the product's efficacy claims.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
160
The slide uses screenshots of Facebook comments to build a case against the drug's efficacy and safety profile.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
161
The slide uses anecdotal evidence from Facebook groups to highlight negative side effects (hyperphagia, behavioral changes) associated with the drug VYKAT.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
162
The slide uses screenshots of Facebook posts to provide qualitative evidence of patient dissatisfaction and safety concerns.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
163
The slide uses direct quotes from Facebook groups to build a case against the drug's efficacy/safety profile.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
164
The slide uses screenshots of Facebook comments to illustrate the divide between frustrated participants and those defending the study.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
165
The slide uses social media screenshots to establish a pattern of adverse events.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
166
The slide uses anecdotal evidence from Facebook discussion groups to highlight potential adverse drug reactions.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
167
The slide uses screenshots of Facebook group posts to provide anecdotal evidence of drug side effects.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
168
The slide uses patient testimonials to contradict the safety profile of the drug Vykat.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
169
The slide uses direct quotes from Facebook discussion groups to build a case against the drug's safety profile.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
170
The slide uses direct quotes from a Facebook discussion group to highlight a patient/caregiver pain point regarding medical monitoring.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
171
The slide uses anecdotal evidence from Facebook groups to challenge the safety profile of the drug Vykat.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
172
The slide uses anecdotal evidence from Facebook groups to challenge the safety profile of the drug Vykat.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
173
The slide uses anecdotal evidence from social media to undermine the perceived value of the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
174
The slide uses anecdotal evidence from Facebook groups to argue against the efficacy of a treatment by highlighting inconsistencies in user reports.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
175
The slide presents a skeptical analysis of patient/parent testimonials to undermine the perceived efficacy of a drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
176
The slide uses social media screenshots to undermine the credibility of a key proponent (Dr. Miller) by showing her own followers are skeptical of the product.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
177
The slide uses anecdotal evidence from Facebook groups to highlight patient dissatisfaction and side effects.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
178
The slide uses direct quotes from Facebook group members to undermine the perceived efficacy and novelty of the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
179
The slide uses anecdotal evidence from Facebook groups to illustrate a safety and compliance issue with the medication's delivery mechanism.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
180
The slide uses screenshots of Facebook group discussions to highlight negative patient experiences.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
181
The slide uses screenshots of Facebook group discussions to highlight patient/caregiver concerns that may contradict or exceed official side effect reporting.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
183
The slide uses a process diagram to illustrate the clinical trial flow, highlighting the transition from the failed C601 trial to the C602 withdrawal study.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
184
The slide uses an excerpt from an FDA label to critique the clinical trial evidence supporting a drug's efficacy.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
185
The slide uses a red box to highlight the specific data points (weeks 12-16 of the withdrawal period) that the author claims are the basis for the company's efficacy argument.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
186
The slide uses a Q&A format to present evidence of potential trial manipulation.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
187
The slide uses a Q&A format to highlight potential data manipulation or questionable internal confidence in clinical trial results.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
188
The slide uses a 'quote-highlight' structure to emphasize specific allegations of misconduct.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
189
The slide uses a Q&A format to present qualitative evidence of investigator misconduct.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit